![]() |
市場調查報告書
商品編碼
2032456
下腔靜脈濾器市場:按產品、材料、應用、最終用戶和地區分類(2026-2034 年)Inferior Vena Cava Filter Market by Product, Material, Application (Treatment Venous Thromboembolism, Prevent Pulmonary Embolism, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2026-2034 |
||||||
2025年,全球下腔靜脈(IVC)濾網市場規模達8.228億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到15.038億美元,2026年至2034年的複合年成長率(CAGR)為6.72%。深層靜脈栓塞症(DVT)和肺動脈栓塞(PE)盛行率的上升、消費者對這些疾病風險和後果的認知不斷提高,以及對微創手術的偏好日益增強,是推動市場成長的主要因素。
下腔靜脈濾器是醫療設備,旨在防止血栓從下半身進入肺部,從而降低肺動脈栓塞的風險。它是一個由金屬或合成材料製成的小型籠狀結構,植入下腔靜脈(下腔靜脈負責將缺氧血液從下半身輸送回心臟)。它透過捕獲血栓並阻止其到達肺部,起到物理屏障的作用。
目前,下腔靜脈濾器在血栓高風險患者中的應用日益廣泛,推動了市場成長。此外,醫療機構優惠的報銷政策也促進了下腔靜脈濾器的使用,進一步推動了市場成長。老年族群(靜脈血栓栓塞症高風險族群)中下腔靜脈濾器的日益普及,也促進了市場成長。此外,全球對微創手術的日益青睞,也帶動了對下腔靜脈濾器需求的成長,對市場產生了正面影響。最後,醫療基礎設施的改善也促進了醫療解決方案的普及,進一步增強了市場成長。
深層靜脈栓塞症(DVT)和肺動脈栓塞(PE)的盛行率增加
在全球範圍內,深層靜脈栓塞症(DVT)和肺動脈栓塞(PE)的盛行率不斷上升,推動了對下腔靜脈濾器(IVC濾器)的需求。深層靜脈栓塞症形成通常是指血液在深層靜脈(通常位於腿部)形成血栓。此外,如果這些血栓脫落並隨血液循環到達肺部,則可能導致危及生命的肺動脈栓塞。久坐的生活方式、肥胖、缺乏運動以及其他生活方式相關的問題正在增加DVT和PE的患病人數。此外,老年族群罹患DVT的風險更高。醫療專業人員也擴大採用IVC濾器作為高風險患者的預防措施,以降低PE的發生率及其相關的發病率和死亡率。
消費者對疾病風險和後果的認知不斷提高
醫療保健專業人員和公眾對深部靜脈栓塞和肺栓塞的風險和後果的認知不斷提高,導致對下腔靜脈濾器的需求增加。
各國監管機構正透過宣傳宣傳活動、教育舉措和其他旨在預防靜脈血栓栓塞症的活動,鼓勵使用下腔靜脈濾器。此外,診斷技術的快速發展使得深部靜脈栓塞(DVT)和肺栓塞(PE)病例的檢測更加準確快捷,從而改善了患者的預後。早期診斷也有助於醫護人員識別哪些患者適合植入下腔靜脈濾網。下腔靜脈濾器作為一種可靠有效的預防肺動脈栓塞的解決方案,其應用日益廣泛,推動了市場成長。
下腔靜脈濾網技術的進步
多家製造商正致力於快速推動下腔靜脈濾器技術,以提高產品的安全性和有效性。此外,可回收式下腔靜脈濾器的應用日益廣泛,這種濾器可在肺動脈栓塞風險消退後取出。這些可回收式濾器為醫療專業人員提供了柔軟性、更有效的患者管理方案,從而提振了市場前景。同時,濾網設計和材料的多項技術進步圖提高其生物相容性,並降低副作用和長期併發症的風險。此外,下腔靜脈濾器有效性的提高也促使其在適用病例的應用率不斷提升。
The global inferior vena cava (IVC) filter market size reached USD 822.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,503.8 Million by 2034, exhibiting a growth rate (CAGR) of 6.72% during 2026-2034. The growing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE), rising consumer awareness about the risks and consequences of diseases, and increasing preference for minimally invasive surgical procedures are some of the major factors propelling the market.
An inferior vena cava (IVC) filter is a medical device that is designed to prevent the migration of blood clots from the lower body to the lungs and reduce the risk of pulmonary embolism. It is a small and cage-like structure that is manufactured from metal or synthetic materials. It is inserted into the inferior vena cava vein that carries deoxygenated blood from the lower body to the heart. It acts as a physical barrier by trapping blood clots and preventing them from reaching the lungs.
At present, the increasing adoption of IVC filters among patients who are at high risk of developing blood clots is contributing to the growth of the market. Apart from this, the rising utilization of IVC filters on account of favorable reimbursement policies by healthcare providers is propelling the growth of the market. Moreover, the increasing adoption of IVF filters among the geriatric population, as they are more prone to venous thromboembolism, is bolstering the growth of the market. Additionally, the growing demand for IVC filters due to the increasing preference for minimally invasive surgical procedures among the masses around the world is positively influencing the market. Furthermore, the rising adoption of medical treatment solutions due to the improving healthcare infrastructure is strengthening the growth of the market.
Rising prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE)
There is a rise in the demand for IVC filters due to the increasing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE) among the masses across the globe. Deep vein thrombosis usually occurs when blood clots form in deep veins, often in the legs. Moreover, if these clots break loose and travel to the lungs, then they can cause a life-threatening condition known as pulmonary embolism. People are increasingly facing DVT and PE cases due to sedentary lifestyles, obesity, improper physical activity, and other lifestyle-related issues. Additionally, there is an increased chance of the development of DVT among the geriatric aging population. Furthermore, healthcare providers are increasingly adopting IVC filters as a preventive measure for high-risk patients to reduce the occurrence of PE and its associated morbidity and mortality.
Increasing consumer awareness about the risks and consequences of diseases
There is an increase in the demand for IVC filters due to the rising awareness about the risks and consequences of DVT and PE among healthcare professionals and the general population.
Governing agencies of various countries are encouraging the adoption of IVC filters by spreading awareness, organizing campaigns, and taking educational initiatives to focus on venous thromboembolism prevention. Moreover, rapid advancements in diagnostic capabilities allow more accurate and timely detection of DVT and PE cases that enhances patient outcomes. In addition, early diagnosis allows healthcare professionals to identify individuals who could benefit from IVC filter placement. The rising utilization of IVC filters to provide a reliable and effective solution for preventing pulmonary embolism is contributing to the growth of the market.
Advancements in IVC filter technology
Various manufacturers are rapidly advancing IVC filter technology to provide improved safety and efficacy of the product. In addition, the rising introduction of retrievable IVC filters, which can be removed once the risk of pulmonary embolism has settled. These retrievable filters provide healthcare professionals with more flexibility and options for managing patients effectively, which is offering a positive market outlook. Additionally, various technological advancements in filter design and materials assist in enhancing biocompatibility and reducing the risk of adverse reactions and long-term complications. Apart from this, the rising adoption rates of IVC filters for appropriate cases due to their enhanced effectiveness.
Retrievable IVC filter represents the largest market segment
Retrievable IVC filters are medical devices that are designed to be implanted temporarily in patients at high risk of pulmonary embolism. They can be removed once the risk of clot migration has subsided or when the condition of the patient is improved. In addition, the retrievable IVC filter placement procedure is minimally invasive and typically performed by an interventional radiologist. The rising adoption of retrievable IVC filters, as they offer flexibility to healthcare providers in treatment options, is propelling the growth of the market.
Non-ferromagnetic material accounts for the majority of the market share
Non-ferromagnetic materials are those that do not contain iron and do not exhibit magnetic properties. They are used to construct filter devices and offer enhanced biocompatibility. They can withstand the physiological environment within the human body without causing adverse reactions. In addition, they are widely used in medical settings where the presence of magnetic materials could interfere with imaging techniques, such as magnetic resonance imaging (MRI). Non-ferromagnetic materials are utilized in the construction of IVC filters that allow patients to undergo MRI scans without any concerns about potential complications or distortions in the images.
Treatment venous thromboembolism (VTE) holds the biggest market share
In the treatment venous thromboembolism (VTE), the IVC filters are placed in the inferior vena cava that carries deoxygenated blood from the lower body to the heart, to trap blood clots and prevent their migration to the lungs. They assist in reducing the risk of pulmonary embolism and its potential consequences in the body. They also provide an additional layer of protection against blood clot migration in high-risk patients. In line with this, VTE treatment provides enhanced patient outcomes and improved overall safety in managing VTE cases.
Hospitals dominate the market share
Hospitals are the primary end-users of IVC filters, as they provide enhanced treatment options to patients with various medical conditions, such as those at high risk of venous thromboembolism (VTE). In hospitals, IVC filters are widely utilized in patients undergoing surgical procedures or those admitted for trauma or critical care, and individuals with known risk factors for developing deep vein thrombosis (DVT) or pulmonary embolism (PE). In addition, hospitals are equipped with advanced medical technologies and experienced healthcare professionals that benefit in managing VTE cases effectively. Interventional radiologists or vascular surgeons often perform the minimally invasive procedure of inserting IVC filters in hospital settings.
North America exhibits a clear dominance, accounting for the largest inferior vena cava (IVC) filter market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the presence of well-established healthcare infrastructure and facilities. In addition, the rising prevalence of obesity among individuals is contributing to the growth of the market in the region. Apart from this, the increasing utilization of IVC filters as a preventive measure among patients is supporting the growth of the market. In line with this, the rising adoption of IVC filers due to favorable regulatory framework and reimbursement policies is bolstering the growth of the market in the North America region.
Key players in the industry are investing in research and development (R&D) activities to improve the design, materials, and safety features of IVC filters. In line with this, they are developing retrievable filters, enhancing the biocompatibility of products, and exploring innovative filter designs to reduce complications and enhance patient outcomes. Apart from this, many companies are launching new IVC filter products or introducing upgraded versions of their existing products to address specific clinical needs. They are also conducting clinical trials and research studies to gather more data on the safety and efficacy of their IVC filter products. In addition, major manufacturers are working to address safety concerns related to IVC filters, such as filter migration, fracture, and perforation.